Background: It is unclear whether Crohn's disease (CD) is associated with skeletal disproportion in adulthood. Methods: Height (Ht), sitting height (SHt) and leg length were studied in 44 children (male: 22), 23 adults (male: 10) with childhoodonset (CO) CD and 26 adults (male: 9) with adult-onset (AO) CD with a median (range) age of 13.7 (10, 17.3), 21.5 (18, 32) and 31.0 (22, 40) years, respectively. Results: Adults with CO-CD had a median Ht standard deviation score (SDS) of -0.9 (-2.3, 0.0) compared to 0.6 (-0.8, 1.0) in those with AO-CD (p < 0.05). Compared to a normal population, men, but not women, with CO-CD also had lower median SHt SDS at -1.1 (2.5, -0.5) (p < 0.05). The expected positive association that is normally found between leg length and SHt SDS was not evident in the adults with CO-CD. Conclusion: Short stature in adults with CO-CD is more pronounced in men and may be associated with poor spinal growth.
Introduction
Crohn's disease (CD) often presents during early adolescence. Clinical presentation is commonly associated with short stature and, historically, delayed puberty. Adults with childhood-onset (CO) CD are shorter than expected for their mid-parental height (Ht) [1] . Although pubertal delay does not seem to be a major concern in children on contemporary therapy, affected children and adolescents with CD continue to remain shorter than the reference population [2] and exhibit suboptimal growth during puberty [3] . We performed a cross-sectional study of Ht and skeletal proportions in children with CD as well as adults with CO-CD and adult-onset (AO) CD to further explore the contribution of pubertal growth.
Patients and Methods
Eligible participants were children <18 years old with CD attending the Royal Hospital for Children, Glasgow, and young adults between the age of 18 and 40 years attending the Glasgow Royal Infirmary, Glasgow. The latter were divided into 2 groups: CO-CD, onset <18 years; AO-CD, disease onset ≥18 years. Prepubertal onset of symptoms was defined using chronological age at onset of symptoms as <13 years for males and <11 years for females [2] . Patients with known endocrinopathies or other co-morbidities that may affect growth or skeletal development were excluded from recruitment. Clinical details were collected from case notes and face-to-face interviews. Anthropometric data were obtained using standard protocols. Ht and sitting height (SHt) were measured with a wall-mounted stadiometer with leg length (LL) calculated as the difference between the Ht and SHt. Parental Hts were measured for the children with CD and were self-reported by the adults with CD; 2 adults with CO-CD and 3 with AO-CD could not recall parental Hts.
All data were expressed as median (range) and analysed (Minitab 16, Coventry, UK). Ht, SHt and LL were expressed as standard deviation scores (SDS), and short stature was defined as Ht SDS ≤-2. A deviation from target/mid-parental Ht SDS was defined as the difference between the target and the patient's actual Ht SDS. One-sample t test was used to compare Ht measurements against the reference UK population data. Mann-Whitney U test was used for inter-group comparisons, and Pearson correlation was used to assess associations between continuous variables. Statistical significance was set at a p < 0.05.
The study was approved by the West of Scotland Research Ethics Committee (10/S0701/66), and each participant provided written consent prior to study enrolment.
Results

Participant Characteristics
Participant characteristics are presented in Table 1 . Of the 92 patients recruited, 44 were children with CD (male: 22), 26 were adults with AO-CD (male: 9) and 23 were adults with CO-CD (male: 10). Pre-pubertal onset of disease was noted in 29/44 (65.9%) children and in 10/23 (43.4%) adults with CO-CD (Table 1) .
Ht and Skeletal Proportions in Children with CD
There was no significant difference in Ht, SHt and LL SDS between girls and boys (Table 1 ). Compared to the UK 1990 reference data, boys but not girls had a median Ht deficit of 0.63 SDS (Table 1) . Whilst both sex groups also had a lower SHt SDS, boys with CD also had a lower LL SDS (Table 1 ). There was a positive correlation between SHt and LL SDS in children with pre-pubertal (r = 0.54; p = 0.003) and pubertal (r = 0.84; p < 0.001) onset of CD (Fig. 1) . The 5 children with the greatest disproportion, either LL SDS ≤-2 or a SHt SDS ≤-2, were amongst those with the lowest Ht SDS. The 4 children (male: 3) with low LL SDS but normal SHt SDS had pre-pubertal onset of CD, and the 1 girl with low SHt SDS but normal LL SDS was diagnosed in mid-puberty.
Final Ht and Skeletal Proportions in Adults with AO-CD and CO-CD
The median Ht SDS and SHt SDS in men with CO-CD were lower than those of AO-CD (Table 1 ). In addition, men with CO-CD also showed a larger deviation from target Ht. However, these men did not show a significant difference in LL SDS (Table 1 ). In women, there was no significant difference in Ht, SHt, LL SDS and deviation from target Ht between participants with CO-CD and those with AO-CD ( Table 1) . The positive association which was evident between SHt and LL SDS for adults with AO-CD (r = 0.47; p = 0.016) was not present in those with CO-CD (r = 0.09; p = 0.677) (Fig. 1) . Notably, 2 patients each had LL SDS ≤-2 or low SHt SDS ≤-2. These 4 represented those with the lowest Ht SDS within the entire group; all were adults with CO-CD (Fig. 1) . The 2 patients with low SHt SDS but normal LL SDS (patients A and B) were diagnosed in mid-puberty, and the 2 patients with low LL SDS but normal SHt SDS (patients C and D) had pre-pubertal onset of CD. In the adults with CO-CD or AO-CD, there was no association of Ht or SHt SDS with the age at onset of disease, disease duration, Montreal classification of disease or the use of biologic therapy as a marker of disease severity.
Discussion
In contemporary cohorts, boys with CD are more likely to have an abnormality of pubertal growth despite satisfactory entry and progress through puberty [3] and are, therefore, at risk of a lower final adult Ht. Poor growth and an abnormality of the growth hormone/insulin-like growth factor 1 axis are evident during periods of active disease and may be related to multiple factors, including malnutrition and an elevation in pro-inflammatory cytokines [4] . In accordance with previous research [1] , the current study suggests that short stature in CO-CD may persist into adulthood. However, the current study also shows that the growth restriction is more likely in boys and may be linked more specifically to a reduction in spinal length. This finding of relative skeletal disproportion is further supported by the lack of association between LL and SHt in adults with CO-CD. Interestingly, the 4 adults displaying the greatest disproportion had the lowest Ht SDS, and all had CO-CD. A previous history of pubertal delay or abnormal pubertal growth provides a possible explanation for skeletal disproportion in adulthood [5] and may explain the greater Ht restriction as well as disproportion seen in boys with CD and men with CO-CD. There is also the possibility that the reduced SHt seen in this study may be related to subclinical vertebral fractures or abnormal vertebral morphology, which is becoming increasingly recognised in young people with chronic inflammatory disease as well as those who require systemic glucocorticoids [6] . Prospective studies would require longitudinal assessment of puberty and radiological assessment of vertebral morphology.
In summary, by showing that short stature in adults with CO-CD is more marked in boys and may be associated with skeletal disproportion, this study provides further mechanistic insight into the effect of childhood chronic disease on growth and skeletal development. 
